Table I.
Aerodynamic methods | Non-aerodynamic methods |
---|---|
Multi-stage cascade impactor and liquid impinger | Laser diffractometry |
Full resolution CIs provide complete APSDs but are slow and labor-intensive | Rapid with high size resolution |
Abbreviated impactor for simplified APSD metrics based on large and small particles (product QC) or coarse, fine, and extra-fine particles (human respiratory tract-relevant metrics) | Can be made non-invasive (no need to sample the aerosol) |
No API specificity hence inapplicable to mixtures of APIs or API + excipient(s) | |
The most useful technique for size analyzing the large droplets from nasal sprays | |
Time-of-flight methods | Laser (phase) Doppler particle size analysis |
Provide APSD directly with high size resolution, but weighting is count- rather than mass-based | Similar to LD in terms of resolution and rapidity |
No API specificity hence may be inapplicable to mixtures of APIs or API + excipient(s) | |
Rapid compared with cascade impaction | |
Complex signal rejection criteria can make representative sampling difficult | |
No API specificity—hence may be inapplicable to mixtures of APIs or API + excipient(s) | |
Single-particle light scattering (optical particle counting) | |
Similar to LD in terms of resolution and rapidity | |
No API specificity hence may be inapplicable to mixtures of APIs or API + excipient(s) | |
Sampling system is needed | |
Microscopy-automated image analysis | |
Requires careful sample capture and preparation | |
Moderately fast with automated image analysis | |
Care needed to define particle boundaries | |
When combined with Raman chemical imaging may provide specificity to API content |
API active pharmaceutical ingredient, CI cascade impactor, LD laser diffractometry, TOF time of flight